Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma

Por Meenhuis, Annemarie, van Vliet, Rianne, Hudig, Francisca, Ypma, Paula F, Schipperus, Martin R, Hollestelle, Martine J
Publicado no Clin Case Rep (2015)

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks

Por Saadah, Nicholas H., Schipperus, Martin R., Wiersum-Osselton, Johanna C., van Kraaij, Marian G., Caram-Deelder, Camila, Beckers, Erik A.M., Leyte, Anja, Rondeel, Jan M.M., de Vooght, Karen M.K., Weerkamp, Floor, Zwaginga, Jaap Jan, van der Bom, Johanna G.
Publicado no Haematologica (2020)

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Por Zwaginga, Jaap J., van der Holt, Bronno, te Boekhorst, Peter A., Biemond, Bart J., Levin, Mark-David, van der Griend, René, Brand, Anneke, Zweegman, Sonja, Pruijt, Hans F.M., Novotny, Vera M.J., Vreugdenhil, Art, de Groot, Marco R., de Weerdt, Okke, van Pampus, Elisabeth C.M., van Maanen-Lamme, Tanja M., Wittebol, Shulamiet, Schipperus, Martin R., Silbermann, Matthijs H., Huijgens, Peter C., Luten, Marleen, Hollestein, Rene, Brakenhoff, Jan A.C., Schrama, Jolanda G., Valster, Fransje A.A., Velders, Gerjo A., Koene, Harry R.
Publicado no Haematologica (2015)